Fortress Biotech, Inc. (FBIO)

Fortress Biotech Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	85.84	83.37	180.95	307.96	235	153.43
Cash & Cash Equivalents	85.84	83.37	180.95	307.96	235	153.43
Cash Growth	-44.59%	-53.93%	-41.24%	31.05%	53.16%	54.69%
Receivables	10.12	15.39	28.35	23.79	24.67	14.4
Inventory	10.58	10.21	14.16	9.86	1.4	0.86
Other Current Assets	10.01	8.06	6.97	4.85	5.08	-12.44
Total Current Assets	116.55	117.02	230.43	346.46	266.15	156.25
Property, Plant & Equipment	22.59	23.5	33.01	34.07	32.41	33.91
Long-Term Investments	0	0	0	0	17.57	11.15
Goodwill and Intangibles	19.47	20.29	27.2	12.55	14.63	7.38
Other Long-Term Assets	6.03	6.72	3.66	3.42	2.66	17.73
Total Long-Term Assets	48.1	50.5	63.87	50.04	67.26	70.17
Total Assets	164.65	167.53	294.3	396.5	333.41	226.42
Accounts Payable	76.38	73.56	97.45	90.66	45.39	35.54
Deferred Revenue	0	0	0	2.61	0	0
Current Debt	6.62	6.45	7.45	2.92	1.85	9
Other Current Liabilities	4.7	4.89	22.82	4.86	4.52	1.07
Total Current Liabilities	87.7	84.91	127.72	101.04	51.76	45.62
Long-Term Debt	79.04	79.14	113.3	63.92	74.57	106.14
Other Long-Term Liabilities	1.85	1.89	3.26	5.66	10.09	2.14
Total Long-Term Liabilities	80.89	81.03	116.56	69.58	84.65	108.27
Total Liabilities	168.58	165.94	244.28	170.63	136.41	153.89
Total Debt	85.66	85.59	120.75	66.84	76.42	115.14
Debt Growth	-29.67%	-29.12%	80.65%	-12.53%	-33.63%	44.83%
Retained Earnings	-710.29	-694.87	-634.23	-547.46	-482.76	-436.23
Shareholders' Equity	23.03	22.54	41.72	108.67	100.34	26.22
Net Cash / Debt	0.18	-2.23	60.21	241.12	158.58	38.29
Net Cash / Debt Growth	-99.47%	-	-75.03%	52.05%	314.15%	94.53%
Net Cash Per Share	0.01	-0.27	10.16	44.27	33.03	10.50
Working Capital	28.85	32.11	102.72	245.42	214.39	110.64
Book Value Per Share	1.34	2.78	7.04	19.95	20.90	7.19

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).